Purchases and Sales Made in Q3 2023 in Beam Therapeutics Inc. (BEAM)
This table provides information about the institutional ownership of Beam Therapeutics Inc. (BEAM) during Q3 2023. The information is specifically focused on institutions that hold shares of Beam Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-45.1K- 6.38% |
$1.04M - $1.46M
|
663K
$11.8M
|
|
|
Nov 14, 2023
Q3 2023
|
Man Group PLC
London, X0 |
SELL
|
- |
-52.8K- 80.11% |
$1.22M - $1.71M
|
13.1K
$233K
|
|
|
Nov 14, 2023
Q3 2023
|
Schroder Investment Management Group
London, X0 |
SELL
|
- |
-92.4K- 59.07% |
$2.13M - $3M
|
64K
$1.14M
|
|
|
Nov 14, 2023
Q3 2023
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-117K- 87.88% |
$2.7M - $3.8M
|
16.2K
$287K
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-195K- 2.78% |
$4.49M - $6.33M
|
6.81M
$121M
|
|
|
Nov 14, 2023
Q3 2023
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-198K- 43.08% |
$4.55M - $6.42M
|
261K
$4.64M
|
|
|
Nov 14, 2023
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-264K- 36.4% |
$6.08M - $8.58M
|
462K
$8.2M
|
|
|
Nov 14, 2023
Q3 2023
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-302K- 22.9% |
$6.94M - $9.79M
|
1.02M
$18M
|
|
|
Nov 15, 2023
Q3 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-313K- 37.48% |
$7.2M - $10.2M
|
522K
$9.27M
|
|
|
Nov 13, 2023
Q3 2023
|
Norges Bank
Oslo, Q8 |
SELL
|
- |
-469KClosed |
$10.8M - $15.2M
|
0
$0
|